期刊
JOURNAL OF CANCER
卷 10, 期 9, 页码 2035-2046出版社
IVYSPRING INT PUBL
DOI: 10.7150/jca.29421
关键词
XBP1; cancer cells; UPR; tumorigenesis; metastasis; drug resistance
类别
资金
- National Natural Science Foundation of China [81660371, 81860388, 81860261]
- Natural Science Foundation of Jiangxi Province [20161BAB215219, 20171BAB215058, 20171BAB205107]
- Scientific Research Fund of Jiangxi Provincial Education Department [GJJ160972, GJJ160990, GJJ170886]
- Innovative Teamwork Project of Gannan Medical University [TD201707]
Cancer cells are usually exposed to stressful environments, such as hypoxia, nutrient deprivation, and other metabolic dysfunctional regulation, leading to continuous endoplasmic reticulum (ER) stress. As the most conserved branch among the three un-folded protein response (UPR) pathways, Inositol-requiring enzyme 1 alpha (IRE1 alpha)-X-box-binding protein 1 (XBP1) signaling has been implicated in cancer development and progression. Active XBPI with transactivation domain functions as a transcription factor to regulate the expression of downstream target genes, including many oncogenic factors. The regulatory activity of XBP1 in cell proliferation, apoptosis, metastasis, and drug resistance promotes cell survival, leading to tumorigenesis and tumor progression. In addition, the XBP1 peptides-based vaccination and/or combination with immune-modulatory drug administration have been developed for effective management for several cancers. Potentially, XBP1 is the biomarker of cancer development and progression and the strategy for clinical cancer management.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据